http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110404074-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate | 2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110404074-B |
| titleOfInvention | Use of OGDH inhibitors in the treatment of viral infectious diseases |
| abstract | The present disclosure relates to the use of inhibitors of alpha-ketoglutarate dehydrogenase (OGDH) in the treatment of viral infectious diseases. In particular, the present disclosure relates to the use of an OGDH inhibitor for the preparation of a product for the treatment of viral infectious diseases and/or symptoms associated with viral infections, and corresponding pharmaceutical compositions or kits thereof. The composition can be used for inhibiting and treating virus infection, particularly for natural immune dysfunction objects, and has wide application prospect. |
| priorityDate | 2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 672.